Davide Campana
Università degli Studi di Bologna
H-index: 41
Europe-Italy
Top articles of Davide Campana
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
OC. 06.3: ITANET NATIONAL PROSPECTIVE DATABASE: A COMPREHENSIVE ANALYSIS OF EPIDEMIOLOGY AND CLINICAL PRESENTATION OF GEP-NEN IN ITALY | Digestive and Liver Disease | F Panzuto S Partelli D Campana S Pusceddu F Spada | 2024/4/1 |
Safety and efficacy of endoscopic ultrasound‐guided radiofrequency ablation for pancreatic neuroendocrine neoplasms: Systematic review and meta‐analysis | Tawfik Khoury Wisam Sbeit Pietro Fusaroli Davide Campana Nicole Brighi | 2024/4 | |
Improved overall survival in patients developing endocrine toxicity during treatment with nivolumab for advanced non-small cell lung cancer in a prospective study | Journal of Endocrinological Investigation | M Albertelli G Rossi E Nazzari C Genova F Biello | 2024/4/29 |
Real-Life Use of [68Ga] Ga-DOTANOC PET/CT in Confirmed and Suspected NETs from a Prospective 5-Year Electronic Archive at an ENETS Center of Excellence: More Than 2000 Scans in … | Cancers | Norma Bonazzi Emilia Fortunati Lucia Zanoni Giulia Argalia Diletta Calabrò | 2024/2/7 |
Gastric neuroendocrine neoplasms | Giuseppe Lamberti Francesco Panzuto Marianne Pavel Dermot O’Toole Valentina Ambrosini | 2024/4/11 | |
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for … | Francesco Panzuto Stefano Partelli Davide Campana Filippo de Braud Francesca Spada | 2024/1/4 | |
Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian Cohort | Journal of Clinical Medicine | Francesco Panzuto Elisa Andrini Giuseppe Lamberti Sara Pusceddu Maria Rinzivillo | 2024/4/3 |
Chemotherapy in well differentiated neuroendocrine tumors (NET) G1, G2, and G3: a narrative review | Arianna Zappi Irene Persano Linda Galvani Elena Parlagreco Elisa Andrini | 2023/1/16 | |
BRAF V600E-mutated large cell neuroendocrine carcinoma responding to targeted therapy: a case report and review of the literature | Gianluca Ricco Renata Seminerio Elisa Andrini Deborah Malvi Elisa Gruppioni | 2023/4/28 | |
Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II … | BMC cancer | Francesca Corti Maria Pia Brizzi Vito Amoroso Dario Giuffrida Francesco Panzuto | 2023/9/26 |
Role of endoscopic resection margin (R1) in the clinical outcome of patients with Neuroendocrine Neoplasia | Endoscopy | M Marasco S Massironi D Campana M Mosca E Dell'unto | 2023/4 |
Impact of Vitamin D Deficiency on Tumor Aggressiveness in Neuroendocrine Neoplasms | Nutrients | Manuela Albertelli Cristian Petolicchio Sara Brasili Andrea Pogna Mara Boschetti | 2023/8/29 |
T. 08.1 ROLE OF ENDOSCOPIC RESECTION MARGIN (R1) IN THE CLINICAL OUTCOME OF PATIENTS WITH NEUROENDOCRINE NEOPLASIA | Digestive and Liver Disease | M Marasco S Massironi D Campana M Mosca E Dell'Unto | 2023/3/1 |
An update on appendiceal neuroendocrine tumors | Elisa Andrini Giuseppe Lamberti Laura Alberici Claudio Ricci Davide Campana | 2023/7 | |
Appendiceal goblet cell carcinoma has marginal advantages from perioperative chemotherapy: a population-based study with an entropy balancing analysis | Langenbeck's Archives of Surgery | Claudio Ricci Davide Campana Carlo Ingaldi Giuseppe Lamberti Laura Alberici | 2023/1/25 |
Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1–2 cm | The Lancet Oncology | Giuseppe Lamberti Elisa Andrini Claudio Ricci Davide Campana | 2023/5/1 |
Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated … | Current Oncology | Nicole Brighi Giuseppe Lamberti Elisa Andrini Cristina Mosconi Lisa Manuzzi | 2023/1/18 |
Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET) | Diagnostics | Giuseppe Lamberti Natalie Prinzi Alberto Bongiovanni Mariangela Torniai Elisa Andrini | 2023/4/29 |
Extrapulmonary Neuroendocrine Carcinomas: Current Management and Future Perspectives | Sara Stumpo Maria Giovanna Formelli Irene Persano Elena Parlagreco Eleonora Lauricella | 2023/12/15 | |
[Lu-177] Lu-DOTA-TATE versus standard of care in adult patients with gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): a cost-consequence analysis from an Italian … | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | Francesca Spada Davide Campana Giuseppe Lamberti Riccardo Laudicella Renato Dellamano | 2022/5/1 |
Co-Authors
